William P. Heaps, A. Packard, Kristina M. McCammon, Tyler P. Green, Joseph P. Talley, Bradley C. Bundy, Dennis Della Corte
The glomerular filtration barrier poses a significant challenge for circulating proteins, with molecules below ~60-70 kDa facing rapid renal clearance. Endogenous proteins have evolved sophisticated evasion mechanisms including oligomerization, carrier binding, electrostatic repulsion, and FcRn-mediated recycling. Understanding these natural strategies provides blueprints for engineering therapeutic proteins with improved pharmacokinetics. This review examines how endogenous proteins resist filtration, evaluates their application in protein engineering, and discusses clinical translation including established technologies (PEGylation, Fc-fusion) and emerging strategies (albumin-binding domains, glycoengineering). We address critical challenges of balancing half-life extension with tissue penetration, biological activity, and immunogenicity-essential considerations for the rational design of next-generation therapeutics with optimized dosing and enhanced efficacy.